Skip to main content

October 10, 2023

Research

Madison schools see surprise enrollment increase

The Capital Times

Soldner said for the actual number of students enrolled, there is an increase of 17 in 3K special programming, 58 fewer students in 4K, 14 more in kindergarten and 48 more in grades 1-12. He said staff will work with the district’s data and research team and outside consultants at the UW Applied Population Lab, which does population projections, to better understand how this affects the overall trend.

Higher Education/System

20% of female college students can’t afford period products, new survey shows

Forbes

The survey included respondents from five schools: Ohio State University, University of Wisconsin at Madison, Harvard University, New York University, and University of Central Florida. A majority (58%) reported working or receiving grants to help cover the cost of living during school. Fourteen percent of respondents reported both receiving financial aid and experiencing period poverty.

Campus life

State news

After questions about use of state funds, budget for Wisconsin Fast Forward workforce development program cut by 16%

Milwaukee Journal Sentinel

Steven Deller studies public finance and economic development at the University of Wisconsin-Madison. Although he doesn’t have direct knowledge of Fast Forward, he said there are “hundreds if not thousands” of federal and state-level grants that are not fully taken advantage of.

There are two main reasons, he said: a lack of awareness and cumbersome application materials. The need to ensure government money is being spent properly creates a lot of paperwork.

“If the agency is perceived as being ‘sloppy’ handing the grants out, there is a huge political price to pay,” Deller wrote via email.

Community

Health

New drug offers hope for UW Health patient with rare, inherited ALS

Wisconsin State Journal

Dr. Collin Kreple, a UW Health neurologist who delivered Francis’ tofersen injection in September, said it may take longer than the short period of the drug’s clinical trial to reveal its clinical effectiveness. Another study has started in people with SOD1 mutations who don’t have symptoms yet.

Athletics

Opinion